BCL9
From Wikipedia, the free encyclopedia
B-cell CLL/lymphoma 9
|
||||||||||||||
PDB rendering based on 2gl7. | ||||||||||||||
Available structures: 2gl7 | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | BCL9; LGS; MGC131591 | |||||||||||||
External IDs | OMIM: 602597 MGI: 1924828 HomoloGene: 3191 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 607 | 77578 | ||||||||||||
Ensembl | ENSG00000116128 | ENSMUSG00000038256 | ||||||||||||
Uniprot | O00512 | Q9D219 | ||||||||||||
Refseq | NM_004326 (mRNA) NP_004317 (protein) |
NM_029933 (mRNA) NP_084209 (protein) |
||||||||||||
Location | Chr 1: 145.48 - 145.56 Mb | Chr 3: 97.29 - 97.3 Mb | ||||||||||||
Pubmed search | [1] | [2] |
B-cell CLL/lymphoma 9, also known as BCL9, is a human gene.[1]
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.[1]
[edit] References
[edit] Further reading
- Willis TG, Zalcberg IR, Coignet LJ, et al. (1998). "Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21.". Blood 91 (6): 1873–81. PMID 9490669.
- Busson-Le Coniat M, Salomon-Nguyen F, Dastugue N, et al. (2000). "Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations.". Leukemia 13 (12): 1975–81. PMID 10602418.
- Kramps T, Peter O, Brunner E, et al. (2002). "Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.". Cell 109 (1): 47–60. PMID 11955446.
- Knoll A, Dvorák J, Rohrer GA, Cepica S (2002). "Linkage and cytogenetic mapping of the BCL9 gene to porcine chromosome 4.". Anim. Genet. 33 (2): 162–3. PMID 12047235.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Townsley FM, Thompson B, Bienz M (2004). "Pygopus residues required for its binding to Legless are critical for transcription and development.". J. Biol. Chem. 279 (7): 5177–83. doi: . PMID 14612447.
- Hoffmans R, Basler K (2004). "Identification and in vivo role of the Armadillo-Legless interaction.". Development 131 (17): 4393–400. doi: . PMID 15294866.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi: . PMID 15302935.
- Sampietro J, Dahlberg CL, Cho US, et al. (2006). "Crystal structure of a beta-catenin/BCL9/Tcf4 complex.". Mol. Cell 24 (2): 293–300. doi: . PMID 17052462.
- Hoffmans R, Basler K (2007). "BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.". Mech. Dev. 124 (1): 59–67. doi: . PMID 17113272.